[Elsevier] Atrasentan in patients with IgA nephropathy (ALIGN): final 2﹞5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-09-10 20:47
Best Answer
29 min. ago
|
| |
| |
| |
post
reply
points
40
10
A state-of-the-art review of experimental and numerical studies on BLEVE overpressure prediction
10
High-performance blue hyperfluorescence OLEDs with precise spatial control of the sensitizing layer in hetero-phase emissive layer for exciton dynamics optimization
10
Provenance variation of the Cambrian-Ordovician sedimentary rocks across South China and implication for its paleogeography in East Gondwana
10
Senescent repair memory in chronic disease: Failed resolution as a driver of persistent organ dysfunction
10
Achieving superior strength-ductility synergy in TiAl alloys via PBF-EB process optimization guided by machine learning-based nondestructive defect prediction
